Study on myeloperoxidase role in antituberculous defense in the context of cytokine activation

Inflammation

Volumn 28, Issue 2, 2004, Pages 53-58

  Koziol Montewka, M ^a   Kolodziejek, A ^a   Oles, J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

IFN ; IL 12; myeloperoxidase; pulmonary tuberculosis; TNF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEMOCONCENTRATION; HUMAN; IMMUNITY; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATIENT; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MIDDLE AGED; PEROXIDASE; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 3142685106     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:IFLA.0000033020.28446.a6     Document Type: Article

References (34)

1. Ottenhoff, T. H. M., E. Spierings, P. H. Nibbering, R. De Jong, and R. R. P. De Vries. 1997. Modulation of protective and pathological immunity in mycobacterial infections. Int. Arch. Allergy Immunol. 113:400-408.
2. Silva, C. L., V. L. D. Bonato, K. M. Lima, A. A. M Coelho-Castelo, L. H. Faccioli, A. Sartori, A. O. De Souza, and S. C. Leão. 2001. Cytotoxic T cells and mycobacteria. FEMS Microbiol. Lett. 197:11-18.
3. Ruan, J., G. S. John, S. Ehrt, L. Riley, and C. Nathan. 1999. noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. Infect. Immun. 67:3276-3283.
4. Firmani, M. A. and L. W. Riley. 2002. Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro. J. Clin. Microbiol. 40:3162-3166.
5. May, M. E. and P. J. Spagnuolo. 1987. Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis. Infect. Immun. 55:2304-2307.
6. Bogdan, C., M. Röllinghoff, and A. Diefenbach. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64-76.
7. Ismail, N., J. P. Olano, H. Feng, and D. H. Walker. 2002. Current status of immune mechanisms of killing of intracellular microorganisms. FEMS Microbiol. Lett. 207:111-120.
8. Winterbourn, C. C., M. C. Vissers, and A. J. Kettle. 2000. Myeloperoxidase. Curr. Opin. Hematol. 7:53-58.
9. Burner, U., P. G. Furtmüller, A. J. Kettle, W. H. Koppenol, and C. Obinger. 2000. Mechanism of reaction of myeloperoxidase with nitrite. J. Biol. Chem. 275:20597-20601.
10. Klebanoff, S. J. 1999. Myeloperoxidase. Proc. Assoc. Am. Physicians 111:383-389.
11. Van Dalen, C. J., C. C. Winterbourn, R. Senthilmohan, and A. J. Kettle. 2000. Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation. J. Biol. Chem. 275:11638-11644.
12. Winterbourn, C. C. and A. J. Kettle. 2000. Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic. Biol. Med. 29:403-409.
13. Whiteman, M., D. C. Hooper, G. S. Scott, H. Koprowski, and B. Halliwell. 2002. Inhibition of hypochlorous acid-induced cellular toxicity by nitrite. Proc. Natl. Acad. Sci. U.S.A. 99:12061-12066.
14. Grattendick, K., R. Stuart, E. Roberts, J. Lincoln, S. S. Lefkowitz, A. Bollen, N. Moguilevsky, H. Friedman, and D. L. Lefkowitz. 2002. Alveolar macrophage activation by myeloperoxidase. A model for exacerbation of lung inflammation. Am. J. Respir. Cell Mol. Biol. 26:716-722.
15. Fenton, M. J., M. W. Vermeiden, S. Kim, M. Burdick, R. M. Strieter, and H. Kornfeld. 1997. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun. 65:5149-5156.
16. MacMicking, J., Q. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Anuu. Rev. Immunol. 15:323-350.
17. MacMicking, I. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 94:5243-5248.
18. Klebanoff, S. J., R. M. Locksley, E. C. Jong, and H. Rosen. 1983. Oxidative response of phagocytes to parasite invasion. Ciba. Found. Symp. 99:92-112.
19. Manca, C., S. Paul, C. E. Barry III, V. H. Freedman, and G. Kaplan. 1999. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect. Immun. 67:74-79.
20. Borelli, V, E. Banfi, M. G. Perrotta, and G. Zabucchi. 1999. Myeloperoxidase exerts microbicidal activity against Mycobacterium tuberculosis. Infect. Immun. 67:4149-4152.
21. Kettle, A. J. and C. C. Winterbourn. 1992. Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone. J. Biol. Chem. 267:8319-8324.
22. Orme, I. M. and A. M. Cooper. 1999. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today 20:307-312.
23. Modlin, R. L. and P. F. Barnes. 1995. IL12 and the human immune response to mycobacteria. Res. Immunol. 146:526-531.
24. Flynn, J. L. and J. D. Ernst. 2000. Immune responses in tuberculosis. Curr. Opin. Immunol. 12:432-436.
25. De Jong, R., F. Altare, I. Haagen, D. G. Elferink, T. De Boer, V. Van Breda, J. C. Peter, P. J. Kabel, J. M. T. Draaisma, J. T. van Dissel, F. P. Kroon, J. Casanova, and T. H. M. Ottenhoff. 1998. Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435-1438.
26. Wang, J., J. Wakeham, R. Harkness, and Z. Xing. 1999.Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J. Clin. Invest. 103:1023-1029.
27. Vanham, G., Z. Toossi, C. S. Hirsch, R. S. Wallis, S. K. Schwander, E. A. Rich, and J. J. Ellner. 1997. Examining a paradox in the pathogenesis of human pulmonary tuberculosis: Immune activation and suppression/anergy. Tuber. Lung Dis. 78:145-58.
28. Kawaguchi, H., Y. Ina, S. Ito, S. Sato, Y. Sugiura, H. Tomita, N. Ogisu, K. Takada, M. Yamamoto, M. Morishita, and K. Yoshikawa. 1996. Serum levels of soluble tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis. Kekkaku 71:259-265.
29. Verbon, A., N. Juffermans, S. J. Van Deventer, P. Speelman, H. Van Deutekom, and T. Van Der Poll. 1999. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 115:110-113.
30. Knoring, B. E., A. S. Simbirtsev, I. Sakharova, A. Kotov, N. V. Pisareva, and T. B. Resnianskaia. 1998. Production of cytokines in different forms of pulmonary tuberculosis. Probl. Tuberk. 3:67-71.
31. Altare, F., A. Durandy, D. Lammas, J. F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Doffinger, F. Bernaudin, O. Jeppsson, J. A. Gollob, E. Meinl, A. W. Segal, A. Fischer, D. Kumararatne, and J. L. Casanova. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435.
32. Lefkowitz, D. L., C. K. Mills, N. Moguilevsky, A. Bollen, A. Vaz, and S. S. Lefkowitz. 1993. Regulation of macrophage function by human recombinant myeloperoxidase. Immunol. Lett. 36:43-49.
33. Srivastava, C. H., T. A. Rado, D. Bauerle, and H. E. Broxmeyer. 1991. Regulation of human bone marrow lactoferrin and myeloperoxidase gene expression by tumor necrosis factor-α. J. Immunol. 146:1014-1019.
34. Kawano, S., E. Tatsumi, N. Yoneda, S. Nagata, and N. Yamaguchi. 1993. Suppression of gene expression of myeloperoxidase (MPO) by gamma-interferon (IFN-gamma) in HL60 cells. Lymphokine Cytokine Res. 12:81-85.